CN101214177A - Method for treating pigmentary degeneration of retina - Google Patents

Method for treating pigmentary degeneration of retina Download PDF

Info

Publication number
CN101214177A
CN101214177A CNA2007101592406A CN200710159240A CN101214177A CN 101214177 A CN101214177 A CN 101214177A CN A2007101592406 A CNA2007101592406 A CN A2007101592406A CN 200710159240 A CN200710159240 A CN 200710159240A CN 101214177 A CN101214177 A CN 101214177A
Authority
CN
China
Prior art keywords
blood supply
retinitis pigmentosa
increase
eyeground
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101592406A
Other languages
Chinese (zh)
Inventor
刘明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENYANG JIREN EYE RESEARCH INSTITUTE
Original Assignee
SHENYANG JIREN EYE RESEARCH INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENYANG JIREN EYE RESEARCH INSTITUTE filed Critical SHENYANG JIREN EYE RESEARCH INSTITUTE
Priority to CNA2007101592406A priority Critical patent/CN101214177A/en
Publication of CN101214177A publication Critical patent/CN101214177A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for remedying retinitis pigmentosa is characterized by comprising the following steps that: 1. a biological membrane is planted into the four directions (outer up, outer down, inner up and inner down directions) at the surface of eyeball surface to increase and improve the blood supply of the retina and the choroids, which restores the function of the eyeground optical cell with low function; 2. at a temporal superficial artery block part, the blood supply to blood vessels is divided for increasing the flux of the eye blood vessels. The present invention adopts an operation manner to protect and improve optic nerve and retinal function by establishing a new blood supply approach to increase the eyeground blood supply, which creates a novel approach for remedying the eyeground ischemic disease, brings new hope to a plurality of the patients with the retinitis pigmentosa and takes great effect on promoting the development of the ophthalmic medical treatment technology.

Description

The method of treatment retinitis pigmentosa
Technical field
The present invention relates to a kind of Therapeutic Method, particularly relate to a kind of method for the treatment of retinitis pigmentosa, belong to the ophthalmic medical technology.
Background technology
The sickness rate of retinitis pigmentosa is 1/3500, is a kind of genetic diseases, shows as nyctalopia in early days, and the visual field is carrying out property and dwindles, and often causes at last losing one's sight.The main pathological change of retinitis pigmentosa is that optical fundus blood vessel attenuates, retinal degeneration, and the optical fundus is ischemic change.In medical field treatment retinitis pigmentosa is a blind area always, is regarded as incurable disease always, does not have its means and methods, and traditional method can only be used Chinese medicine and vasodilator, but does not all have obvious curative effects.
Summary of the invention
The objective of the invention is to overcome the deficiency that prior art exists, propose a kind of method for the treatment of retinitis pigmentosa.Method of this treatment retinitis pigmentosa solves the situation of optical fundus ischemia by modus operandi, the optical fundus function is improved and improves.
The technical solution that the present invention provides is: the method for this treatment retinitis pigmentosa is characterized in including the following step:
1, biomembrane is implanted the wall of eyeball surface four direction (outer go up, outer down, interiorly go up, interior down), increase and improve retina and choroidal blood supply, the optical fundus visual cell function of hypofunction is restored;
2, at the superficial temporal artery blocking part, the blood supply of branch vessel makes it to increase the flow of ocular angiogenesis.
Compared with prior art; beneficial effect of the present invention is: the mode that adopts operation; increase the optical fundus blood supply by setting up new blood supply approach; make optic nerve; retinal function is protected and improves; for the treatment of retinopathy opens up a new way, brought new hope for numerous patients with retinitis pigmentosa, great impetus has been played in the development of ophthalmic medical technology.
Description of drawings
Fig. 1 provides operation (eyeball front) sketch map that biomembrane is implanted for step 1 of the present invention;
Fig. 2 provides operation (eyeball side) sketch map that biomembrane is implanted for step 1 of the present invention;
Fig. 3 provides the operation chart of superficial temporal artery shunting for step 2 of the present invention.
The specific embodiment
Below in conjunction with embodiment concrete technical scheme of the present invention is described further:
As Fig. 1~shown in Figure 3, the method for this treatment retinitis pigmentosa includes the following step:
1, biomembrane 1 is implanted eyeball 2 wall surfaces four direction (go up outward, outer down, interiorly go up, interior down), increase and improve retina and choroidal blood supply, the optical fundus visual cell function of hypofunction is restored;
2, at superficial temporal artery 3 blocking parts, the blood supply of branch vessel 4 makes it to increase the flow of ocular angiogenesis 5.
The present invention adopts the mode of operation to treat retinitis pigmentosa; increase the optical fundus blood supply by setting up new blood supply approach; make optic nerve; retinal function is protected and improves; for the treatment of retinopathy opens up a new way; brought new hope for numerous patients with retinitis pigmentosa, great impetus has been played in the development of ophthalmic medical technology.

Claims (1)

1. treat the method for retinitis pigmentosa, it is characterized in that including the following step:
(1), with biomembrane implant the wall of eyeball surface four direction (outer go up, outer down, interiorly go up, interior down), increase and improve retina and choroidal blood supply, the optical fundus visual cell function of hypofunction is restored;
(2), at the superficial temporal artery blocking part, the blood supply of branch vessel makes it to increase the flow of ocular angiogenesis.
CNA2007101592406A 2007-12-27 2007-12-27 Method for treating pigmentary degeneration of retina Pending CN101214177A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101592406A CN101214177A (en) 2007-12-27 2007-12-27 Method for treating pigmentary degeneration of retina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101592406A CN101214177A (en) 2007-12-27 2007-12-27 Method for treating pigmentary degeneration of retina

Publications (1)

Publication Number Publication Date
CN101214177A true CN101214177A (en) 2008-07-09

Family

ID=39620726

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101592406A Pending CN101214177A (en) 2007-12-27 2007-12-27 Method for treating pigmentary degeneration of retina

Country Status (1)

Country Link
CN (1) CN101214177A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102994507A (en) * 2011-09-13 2013-03-27 四川大学华西医院 Retinitis pigmentosa related gene identification, and product, method and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102994507A (en) * 2011-09-13 2013-03-27 四川大学华西医院 Retinitis pigmentosa related gene identification, and product, method and use thereof
CN102994507B (en) * 2011-09-13 2015-05-20 四川大学华西医院 Retinitis pigmentosa related gene identification, and product, method and use thereof

Similar Documents

Publication Publication Date Title
CN104768505A (en) Ocular collar stent for treating narrowing of the irideocorneal angle
CN205094967U (en) Multiple mode therapeutic instrument of ophthalmology
CN201029958Y (en) Non-penetrating integrated artificial cornea
CN106420809B (en) A kind of ophthalmologic operation perfusion liquid
CN101214177A (en) Method for treating pigmentary degeneration of retina
Presland et al. Ocular anatomy and physiology relevant to anaesthesia
Presland et al. Ocular anatomy and physiology relevant to anaesthesia
US10258463B2 (en) Phakic intraocular lens implantation without viscoelastics and instrument thereof
Ashton et al. Pathology of an aphakic eye containing an anterior chamber implant
RU2395255C1 (en) Method of surgical treatment of through idiopathic macular rupture
CN201073376Y (en) Novel myopic eye massage and treatment equipment
CN204468416U (en) Inflated type oxygen therapy rehabilitation eye-mask
RU2425661C2 (en) Method of treating primary open-angle glaucoma
RU2472476C1 (en) Method of laser treatment of fused drusen in case of age-related macular degeneration
Yang et al. Two cases of orbital infarction syndrome.
RU2256430C1 (en) Method for implanting intracorneal lens
RU2071303C1 (en) Method to treat turbidity of clear ocular media
Presland et al. Ocular anatomy and physiology relevant to anaesthesia
RU2486879C1 (en) Method of surgical treatment of trophic ulcers of cornea and progressive keratitis
CN210582821U (en) Cross-lamina pressure balance retainer and implant device for continuously balancing pressure difference across lamina cribosa
CN208145079U (en) A kind of interim cornea of novel artificial
CN202313922U (en) Crystal implantation forceps for ophthalmological surgery
CN112674932A (en) Light biological regulation therapeutic apparatus for treating open-angle glaucoma and using method
RU2235526C1 (en) Method for treating the cases of sclerotic retinal maculodystrophy
RU2326632C1 (en) Method of ophthalmodisintoxication at inflammatory, vascular and dystrophic diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080709